-10.2%
AVGO vs THC
+50.5%
-60.7%
-39.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +8.8% | +2.0% | +6.8% | +8.6% |
| 7D | -0.9% | +7.5% | -8.3% | -1.2% |
| 30D | -11.6% | +9.6% | -21.2% | -12.1% |
| 3M | -25.2% | +10.3% | -35.4% | -25.6% |
| 6M | -25.4% | +51.8% | -77.3% | -28.2% |
| YTD | -7.2% | +45.4% | -52.6% | -11.0% |
| All | -10.2% | +50.5% | -60.7% | -15.4% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling